ARCHIVES

Intarferon Results Promising, ACS Says, And commits Another $3.4 Million

This article is from The Cancer Letter archive.

Vol. 06 No. 08 | February 22, 1980

Download PDF Visit The Full Archive

Related Articles

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

November 23, 1979

In Sign-Off Of Two Orphan Drugs, ODAC Leaves Efficacy Interpretation To Docs

November 27, 1998

Freeman Reappointed President’s Cancer Panel Chairman

September 16, 1994

Nominations Open for Bristol-Myers $25,000

September 29, 1978

NCI to Support Research and Development Of Image Guided Therapy for Prostate Cancer

July 16, 1999

Lurie Center At Northwestern Wins Core Grant Renewal.

December 7, 2001